BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35280831)

  • 1.
    Razzaghi-Asl N; Mirzayi S; Mahnam K; Adhami V; Sepehri S
    Res Pharm Sci; 2022 Apr; 17(2):189-208. PubMed ID: 35280831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
    Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
    J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
    Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
    Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein.
    Soumia M; Hajji H; El Mzibri M; Younes FZ; Mohammed B; Mohamed B; Benaissa M
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening.
    Sirous H; Campiani G; Calderone V; Brogi S
    Comput Biol Med; 2021 Oct; 137():104808. PubMed ID: 34478925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
    Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
    Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
    Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
    J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based design and MD simulations of human papilloma virus-16 E6 protein inhibitors.
    Vemula V; Marudamuthu AS; Prasad S; B M S; S E M; A S; Seal P; Alagumuthu M
    J Biomol Struct Dyn; 2024; 42(1):288-297. PubMed ID: 37098806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment.
    Zarezade V; Abolghasemi M; Rahim F; Veisi A; Behbahani M
    J Mol Model; 2018 Nov; 24(12):337. PubMed ID: 30415281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual Screening for Potential Inhibitors of High-Risk Human Papillomavirus 16 E6 Protein.
    Kumar S; Jena L; Mohod K; Daf S; Varma AK
    Interdiscip Sci; 2015 Jun; 7(2):136-42. PubMed ID: 26199214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis.
    Kumar S; Jena L; Galande S; Daf S; Mohod K; Varma AK
    Genomics Inform; 2014 Jun; 12(2):64-70. PubMed ID: 25031569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein.
    Kumar S; Jena L; Mohod K; Daf S; Varma AK
    Interdiscip Sci; 2015 Feb; ():. PubMed ID: 25663107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
    Sirous H; Chemi G; Campiani G; Brogi S
    Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
    Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
    Front Immunol; 2018; 9():3000. PubMed ID: 30619353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With
    Tutumlu G; Dogan B; Avsar T; Orhan MD; Calis S; Durdagi S
    Front Chem; 2020; 8():167. PubMed ID: 32328476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
    Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
    J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided identification of lead compounds as Staphylococcal epidermidis FtsZ inhibitors using molecular docking, virtual screening, DFT analysis, and molecular dynamic simulation.
    Tripathy S; Sahu SK; Azam MA; Jupudi S
    J Mol Model; 2019 Nov; 25(12):360. PubMed ID: 31773394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Dynamics Simulations of Novel Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of Streptococcus Pneumoniae.
    Suvaithenamudhan S; Parthasarathy S
    Curr Comput Aided Drug Des; 2017; 13(3):234-248. PubMed ID: 28260518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein.
    Ahammad F; Alam R; Mahmud R; Akhter S; Talukder EK; Tonmoy AM; Fahim S; Al-Ghamdi K; Samad A; Qadri I
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.